Stephens Starts Ideaya Biosciences (IDYA) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts IDYA Hot Sheet
Price: $31.96 -2.83%
Rating Summary:
25 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
25 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
Stephens analyst Sudan Loganathan initiates coverage on Ideaya Biosciences (NASDAQ: IDYA) with a Overweight rating and a price target of $51.00.
For an analyst ratings summary and ratings history on Ideaya Biosciences click here. For more ratings news on Ideaya Biosciences click here.
Shares of Ideaya Biosciences closed at $26.64 yesterday.
You May Also Be Interested In
- Ideaya Biosciences (IDYA) PT Lowered to $44 at Mizuho
- Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens - Doctor Feedback for Darovasertib Positive
- Tigress Financial Partners Resumes Southwest (LUV) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
